Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

Pfizer's strong R&D pipeline, 7.5%+ dividend yield, & undervalued PE ratio make PFE stock a compelling investment opportunity ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...

A key vaccine advisory committee is meeting for the first time under new U.S. Health Secretary Robert F. Kennedy Jr., a ...

In the first meeting of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) ...

Examine, a free weekly newsletter covering science with a sceptical, evidence-based eye, is sent every Tuesday. You’re ...

American journalist Megyn Kelly has claimed that she developed an autoimmune disorder after taking two doses of the Pfizer COVID-19 vaccine and a follow-up booster in 2021. "I wish I hadn't done it, ...

The CDC's expert panel explores narrowing COVID-19 booster shot guidelines to focus on high-risk groups. Despite concerns ...

Officials say the Army has reenlisted more than 23 soldiers who were discharged for refusing the COVID-19 vaccine.

You may know 175-year-old pharmaceutical company Pfizer (NYSE: PFE) best for its COVID-19 vaccine, but investors have long ...